当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析 - 现金流量表

迈威生物-U

(688062)

  

流通市值:51.32亿  总市值:99.58亿
流通股本:2.30亿   总股本:4.47亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金267,253,700.42124,793,542.94910,664,443.86784,231,938.25
  收到的税费返还112,735.56112,735.56--
  收到其他与经营活动有关的现金45,090,296.722,828,099.0484,475,773.3478,534,635.2
  经营活动现金流入小计312,456,732.7127,734,377.54995,140,217.2862,766,573.45
  购买商品、接受劳务支付的现金46,704,503.334,548,985.211,712,770.838,395,722.25
  支付给职工以及为职工支付的现金271,170,752.48109,119,532.69477,797,910.92366,163,109.94
  支付的各项税费17,954,277.354,874,753.7152,122,393.1438,664,708.12
  支付其他与经营活动有关的现金485,565,637.27243,354,277.06743,730,308.73552,574,502.73
  经营活动现金流出小计821,395,170.43361,897,548.661,285,363,383.62965,798,043.04
  经营活动产生的现金流量净额-508,938,437.73-234,163,171.12-290,223,166.42-103,031,469.59
二、投资活动产生的现金流量:
  收回投资收到的现金123,372,4306,933,200228,985,135.19181,873,582.18
  取得投资收益收到的现金1,062,095.03474,653.071,241,523.52531,987.94
  处置固定资产、无形资产和其他长期资产收回的现金净额--630-
  投资活动现金流入小计124,434,525.037,407,853.07230,227,288.71182,405,570.12
  购建固定资产、无形资产和其他长期资产支付的现金61,586,319.7644,915,404.17157,710,880.15131,275,194.6
  投资支付的现金203,582,700.9462,047,994.3271,831,389.99225,635,960.26
  取得子公司及其他营业单位支付的现金---26,555,538.48
  投资活动现金流出小计265,169,020.7106,963,398.47429,542,270.14383,466,693.34
  投资活动产生的现金流量净额-140,734,495.67-99,555,545.4-199,314,981.43-201,061,123.22
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,095,186,592.82-200,000,000200,000,000
  其中:子公司吸收少数股东投资收到的现金--200,000,000200,000,000
  取得借款收到的现金1,095,301,805.3739,980,0002,465,810,0001,285,840,000
  发行债券收到的现金85,000,00085,000,000400,000,000-
  收到其他与筹资活动有关的现金100,000,000100,000,000200,000,000200,000,000
  筹资活动现金流入小计2,375,488,398.12924,980,0003,265,810,0001,685,840,000
  偿还债务支付的现金798,729,694.78564,974,555.632,230,263,124.621,023,767,117.94
  分配股利、利润或偿付利息支付的现金46,588,753.1324,007,044.2378,381,481.0757,896,342.12
  支付其他与筹资活动有关的现金95,668,579.7442,573,258.19165,240,544.3786,929,089.58
  筹资活动现金流出小计940,987,027.65631,554,858.052,473,885,150.061,168,592,549.64
  筹资活动产生的现金流量净额1,434,501,370.47293,425,141.95791,924,849.94517,247,450.36
四、汇率变动对现金及现金等价物的影响-17,235,653.31-2,610,067.84-3,613,540.5-1,291,825.48
五、现金及现金等价物净增加额767,592,783.76-42,903,642.41298,773,161.59211,863,032.07
  加:期初现金及现金等价物余额1,526,339,326.821,526,339,326.821,227,566,165.231,227,566,165.23
  期末现金及现金等价物余额2,293,932,110.581,483,435,684.411,526,339,326.821,439,429,197.3
补充资料:
  净利润-524,204,538.99--972,257,776.24-
  资产减值准备481,387.49-11,264,036.4-
  固定资产和投资性房地产折旧90,079,096.69-177,940,376.07-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧90,079,096.69-177,940,376.07-
  无形资产摊销4,059,675.77-8,043,802.9-
  长期待摊费用摊销849,232.53-1,603,412.57-
  递延收益摊销-2,779,159.06-1,139,792.65-
  处置固定资产、无形资产和其他长期资产的损失-299,576.7--199,411.91-
  固定资产报废损失19,229.69-97,022.88-
  公允价值变动损失-55,111.12--1,122,391.35-
  财务费用74,198,930.71-95,368,255.97-
  投资损失5,044,913.78-9,601,531.63-
  递延所得税0-0-
  其中:递延所得税资产减少9,650,833.79-5,837,014.9-
    递延所得税负债增加-9,650,833.79--5,837,014.9-
  存货的减少-10,286,695.65-12,521,458.31-
  经营性应收项目的减少-32,100,075.28--30,299,881.87-
  经营性应付项目的增加-130,684,445.75-366,809,526.68-
  现金的期末余额2,225,962,689.15-1,526,339,326.82-
  减:现金的期初余额1,526,339,326.82-1,191,693,931.96-
  加:现金等价物的期末余额67,969,421.43---
  减:现金等价物的期初余额--35,872,233.27-
  现金及现金等价物的净增加额767,592,783.76-298,773,161.59-
公告日期2026-08-312026-04-292026-03-252025-10-31
审计意见(境内)标准无保留意见
TOP↑